Effect of Reminiscence Therapy on Older Adults

December 2, 2022 updated by: Done Gunay, Cumhuriyet University

Effect of Reminiscence Therapy on Functioning of Older Adults: A Randomized Controlled Study

This study was conducted to examine the effect of reminiscence therapy on the functionality of older adults aged 65 and over living in nursing homes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

ABSTRACT Objective : This study was conducted to examine the effect of reminiscence therapy on the level of functionality of individuals aged 65 and over.

Method: The sample of the study consisted of 16 residents who lived in a public nursing home between December 2019 and February 2020 and agreed to participate in the study. Participants were divided into intervention and control groups using the simple random sampling method. Reminiscence therapy was performed with each participant in the intervention group for 8 weeks. The participants in the control group received routine services and were regularly visited for 8 weeks. The research data were obtained by implementing the "Personal Information Form," "Multidimensional Observation Scale for Elderly Subjects (MOSES), and "Mini Mental State Examination (MMSE)" with all participants before the reminiscence therapy and at the end of week eight. Non-parametric tests were completed in analyzing the data as the sample size was lower than 30.

Findings: It was determined that 87.5% of the participants in the intervention group had a chronic disease, 50% were male, and 37.5% were elementary school graduates. All the participants in the control group had a chronic disease, 62.5% were male, and 50% were elementary school graduates. When the pre- and post-reminiscence therapy results were compared, a significant difference was found in the MMSE and MOSES (in the areas of disoriented behavior, depressed/anxious mood, and withdrawn behavior) scores in the intervention group. In the post-test evaluation, a significant difference was found between the intervention and comparison group in MOSES scores. It was determined that the participants in the intervention group that received reminiscence therapy had better functional and cognitive competency than the control group in the areas of self-care, depression/anxiety, and withdrawal from society.

Conclusion: It was concluded that the reminiscence therapy contributed to increase the mental competence and functionality of the older adult participants.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Sivas, Turkey
        • Sivas Cumhuriyet Univercity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 90 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • were 65 years of age and older
  • had a Standardized Mini Mental Test (SMMT) score between 24 and 30
  • Individuals who did not have communication difficulties and mental problems
  • agreed to participate in the study were included in the study sample.

Exclusion Criteria:

  • were 64 years of age and younger
  • have communication difficulties and mental problems
  • had a Standardized Mini Mental Test (SMMT) score 24 and more less
  • nor agreed to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Reminisence Therapy
The participants in the intervention group received reminiscence therapy which was implemented by the researcher as one session per week for eight weeks. In the reminiscence sessions, mnemonic materials selected specifically for the determined interview topic were used. In the sessions, topics such as childhood life, work life, religious holidays, national holidays, old songs, military ceremonies, wedding ceremonies, gardening and field work were shared. In the reminiscence sessions, the participants were encouraged to verbally express the feelings and thoughts they remembered about the mnemonics. The interviews were recorded by the researcher and each session lasted 45-60 minutes. At the end of the reminiscence session, the topics addressed in the session were summarized by the researcher.
Other: The Reminisence Therapy
Reminiscence sessions were held in a meeting room in the nursing home and arranged in accordance with the interviews. In the reminiscence sessions, mnemonic materials selected specifically for the determined interview topic were used. The materials to be used in the reminiscence sessions were determined in accordance with the education level and cultural characteristics of the participants. In the sessions, topics such as childhood life, work life, religious holidays, national holidays, old songs, military ceremonies, wedding ceremonies, gardening and field work were shared. In the reminiscence sessions, the participants were encouraged to verbally express the feelings and thoughts they remembered about the mnemonics. The interviews were recorded by the researcher and each session lasted 45-60 minutes. At the end of the reminiscence session, the topics addressed in the session were summarized by the researcher, the following weeks topic was determined and the interview was concluded.
No Intervention: Control Group
Interviews were conducted with the individuals in the control group on a designated day of the week, at a designated place in the nursing home. The researcher interviewed the individuals in the control group once a week for eight weeks. During these meetings, daily issues and events such as health, sports, and weather were discussed. Each of the mentioned interviews lasted 45-60 minutes. At the end of eight weeks, SMMT and the "Multidimensional Observation Scale for Elderly Individuals" were implemented again to the participants in the intervention and control groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Standardized Mini-Mental State Exam (MMSE):
Time Frame: 5 minutes
Developed by Folstein et al., SMMT is a short, useful, and standardized assessment tool that can be used to determine the cognitive level globally. The test consists of five subsections: orientation of time and space, recording memory, attention, recall, and language. MMSE can be applied by physicians, nurses, and psychologists in a short time. The highest score that can be obtained in MMSE is 30. In the test, a score of 24-30 points is considered normal, 20-23 mild dementia, 10-19 moderate dementia, and 0-9 advanced dementia (Folstein et al. 1975). The validity and reliability study of the test for Turkish population was completed by Güngen et al. (2002).
5 minutes
Multidimensional Observation Scale for Elderly Subjects (MOSES):
Time Frame: 15 minutes
MOSES is a multi-dimensional measurement tool developed by Helmes, Csapo, and Short to evaluate the functionality of older adults (Helmeset al., 1987). The scale consists of 40 questions and provides evaluation in 5 functional sub-dimension areas. The dimensions of the scale are Self-Care , Disorientation , Depressed/Anxious Mood, Irritable behavior, and Withdrawal from society. Each item in the scale is scored between 0 and 4. Twenty-two items of the scale have 4 choices and 18 items have 5 choices. The last option in the five-choice items was created with the thought that the older adult would not be able to answer the question and/or the question would not be suitable for the older adult. The lowest score that can be obtained from the scale is 0, and the highest score is 138. A low score indicates that the functionality of the older adult is high, while a high score indicates that the functionality of the older adult is low (Helmes et al. 1987).
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cumhuriyet University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2019

Primary Completion (Actual)

February 1, 2020

Study Completion (Actual)

February 1, 2020

Study Registration Dates

First Submitted

November 10, 2022

First Submitted That Met QC Criteria

November 22, 2022

First Posted (Actual)

December 2, 2022

Study Record Updates

Last Update Posted (Actual)

December 5, 2022

Last Update Submitted That Met QC Criteria

December 2, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • TELGUNAY1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

It will be shared after the article is published.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nurse's Role

Clinical Trials on The Reminisence Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe